Evidence map›Paper›PMID 31426681›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2019

Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients.

Hamiyet Donmez-Altuntas, Fahri Bayram, Ayse N Coskun-Demirkalp, Osman Baspınar, Derya Kocer, Peter P Toth

Abstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hamiyet Donmez-AltuntasDepartment of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri 38030, Turkey.ORCID 0000-0001-6473-5813
Fahri BayramDepartment of Endocrinology and Metabolism, Faculty of Medicine, Erciyes University, Kayseri 38030, Turkey.
Ayse N Coskun-DemirkalpDepartment of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri 38030, Turkey.
Osman BaspınarDepartment of Internal Diseases, Kayseri Education and Research Hospital, Health Sciences University, Kayseri 38080, Turkey.
Derya KocerDepartment of Biochemistry, Kayseri Education and Research Hospital, Health Sciences University, Kayseri 38080, Turkey.
Peter P TothThe Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD 21287, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA Damage8-Hydroxy-2'-DeoxyguanosineAdultAgedCase-Control StudiesChromosomes, HumanCytokinesisDyslipidemiasFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMicronucleus TestsMiddle Aged8-Hydroxy-2'-DeoxyguanosineHydroxymethylglutaryl-CoA Reductase Inhibitors8-hydroxy-2′-deoxyguanosine levelscytokinesis-block micronucleus cytome assayDNA damageDyslipidemiamicronucleusstatin therapy

Identifiers

PMID31426681
PMCPMC6775566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.